Led by Ali Asilian, Department of Dermatology, School of Medicine Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, a team of investigators compared the effect of topical pimecrolimus and microneedling on refractory stable vitiligo when used alone or in combination.

The team observed the combination therapy of microneedling and topical pimecrolimus 1% treatment produced more favorable overall outcomes, compared to monotherapy.

Read the full article at www.hcplive.com